No timeline set for FDA’s menthol report
CSP Daily News
ROCKVILLE, Md. — As the tobacco industry awaits a decision on menthol from the FDA’s Center for Tobacco Products (CTP), Dr. Lawrence Deyton, CTP director, took time to provide information to CSP Daily News/Tobacco E-News about where the process currently stands.
Deyton explained that the menthol report provided to the CTP by the Tobacco Products Scientific Advisory Committee was a requirement of the Tobacco Control Act and “just that, advisory.” That report, released in March 2011, concluded that the “removal of menthol cigarettes from the marketplace would benefit public health in the United States.”